Botox Cosmetic and Dysport are both prescription injectable neuromodulators made from botulinum toxin type A.
They work by temporarily reducing activity in selected muscles.
In aesthetic treatment, this can soften dynamic wrinkles—lines that become more noticeable when you frown, squint, smile or raise your eyebrows.
But choosing between Botox and Dysport should not simply come down to asking which brand is “better.”
The location of the wrinkles, facial anatomy, muscle strength, previous treatment response, aesthetic goals and FDA-approved indications all matter.
Botox Cosmetic contains onabotulinumtoxinA.
It is injected into selected muscles to temporarily reduce the muscle activity responsible for certain facial lines.
Cosmetic treatment can be used to soften expression-related wrinkles while preserving an appearance appropriate for the individual patient's goals and anatomy.
Botox should not be confused with dermal filler.
Botox affects targeted muscle activity. Fillers are used for different purposes, including adding or restoring volume. Learn more about Botox injections at Park Slope Laser Aesthetic Center.
Dysport contains abobotulinumtoxinA.
Like Botox, it is a botulinum toxin type A product that temporarily reduces activity in targeted muscles.
In the United States, Dysport has an FDA-approved cosmetic indication for temporary improvement in the appearance of moderate-to-severe glabellar lines—the vertical frown lines between the eyebrows—in appropriate adult patients.
No.
They belong to the same general category of treatment, but Botox and Dysport are different prescription products with different formulations and dosing systems.
Their units are not interchangeable.
For that reason, patients should not compare the number of Botox units with the number of Dysport units as though they represented the same measurement.
The appropriate dose is determined according to the specific product being used and the individual treatment plan.
Dynamic wrinkles develop partly because facial muscles repeatedly move the overlying skin.
Examples include:
Neuromodulators such as Botox and Dysport target the muscle activity contributing to these expression lines.
This is different from wrinkles caused primarily by volume loss, significant skin laxity, sun damage or changes in skin texture.
Those concerns may require different treatments.
The vertical lines that develop between the eyebrows are known as glabellar lines or “11 lines.”
They are created partly by repeated contraction of muscles used when frowning or concentrating.
Both Botox Cosmetic and Dysport have FDA-approved cosmetic uses involving moderate-to-severe glabellar lines in appropriate adults.
This is therefore the facial area where a direct Botox-versus-Dysport discussion is particularly relevant.
Which product is selected should depend on the patient's anatomy, muscle activity, previous response, treatment goals and the clinical judgment of the treating professional.
Horizontal forehead lines are strongly influenced by the frontalis muscle.
The frontalis raises the eyebrows.
Every time you raise your eyebrows, the skin of the forehead folds horizontally.
Over many years, these expression lines can become visible even when the forehead is relaxed.
Botox Cosmetic has an FDA-approved cosmetic indication for temporary improvement of moderate-to-severe forehead lines associated with frontalis muscle activity in adults.
This is where understanding FDA-approved indications becomes important.
Botox Cosmetic has an FDA-approved cosmetic indication for forehead lines.
Dysport's U.S. aesthetic indication is for glabellar lines.
A healthcare professional may sometimes use an FDA-approved medication for an indication that is not specifically listed in its labeling. This is generally referred to as off-label use.
Patients should understand which product is being used, where it is being injected and why it was selected.
The forehead should not be evaluated in isolation.
The frontalis muscle helps elevate the eyebrows, while other muscles pull the brow downward or inward.
Changing this balance can affect eyebrow position and facial expression.
That is why simply asking for “more Botox” in the forehead is not necessarily the right strategy.
Treatment should consider:
The goal is an individualized treatment plan rather than applying the same injection pattern to every face.
Crow's feet are the lines extending outward from the corners of the eyes.
They become especially noticeable when smiling or squinting.
The orbicularis oculi muscle contributes to their formation.
With repeated movement and changes in the skin associated with aging and sun exposure, these lines can become increasingly visible.
Botox Cosmetic has an FDA-approved cosmetic indication for temporary improvement in the appearance of moderate-to-severe lateral canthal lines, commonly called crow's feet, in adults.
Dysport's U.S. cosmetic indication is for glabellar lines.
Therefore, someone specifically researching an FDA-approved treatment for crow's feet should understand that distinction.
Again, this does not mean that every patient requires the same treatment plan or dose.
For an appropriate patient, multiple upper-face areas may be evaluated during the same consultation.
This can be useful because facial muscles interact.
Rather than treating one wrinkle in isolation, the provider can evaluate how the eyebrows, forehead, glabella and eye area move together.
Whether multiple areas should actually be treated during the same appointment depends on the individual.
You may see claims online that one product always works faster than the other.
Individual onset varies.
Rather than choosing treatment solely because of a promised difference of a day or two, it is more useful to consider the treatment area, product labeling, previous response, anatomy and desired result.
Patients should also understand that the first noticeable change and the final treatment effect are not necessarily the same thing.
Neither product should be promised to last longer for every patient.
Duration varies according to factors such as:
Both treatments are temporary.
Repeat treatment may be considered when the effect diminishes and when medically appropriate.
This is another area where oversimplified online comparisons can be misleading.
You may see Dysport described as “spreading more” and Botox as being more “precise.”
These statements should not be treated as universal rules for predicting an individual patient's result.
Clinical outcome depends on the product, dose, injection placement, anatomy and technique.
Product selection should therefore be based on clinical considerations rather than a marketing slogan about diffusion.
It is misleading to tell patients that Dysport is simply a diluted version of Botox.
Botox and Dysport are distinct formulations with their own approved dosing systems.
Their units cannot be directly converted as though they were the same medication.
This is one reason comparing price per unit between the two products can also be misleading.
Price per unit does not provide a meaningful direct comparison because Botox units and Dysport units are not interchangeable.
One product may require a numerically different number of units from the other.
What matters to the patient is the overall treatment plan and total treatment cost—not simply which brand advertises a lower price per unit.
Neither Botox nor Dysport automatically produces a more natural-looking result.
Natural appearance depends heavily on:
Some patients want substantial reduction in movement, while others prefer to retain more expression.
That preference should be discussed before treatment.
An unnatural or overly restricted appearance is not an inevitable consequence of neuromodulator treatment.
The amount and placement of product affect the result.
A conservative, individualized approach may preserve more movement while still softening selected expression lines.
Patients should communicate how much movement they would like to retain.
Men can also be candidates for neuromodulator treatment.
Muscle size and strength can differ substantially among individuals, and some men may have relatively strong facial muscles.
Treatment should therefore be based on actual anatomy rather than using a predetermined dose based only on gender.
Neuromodulators temporarily reduce the repeated muscle activity that contributes to dynamic expression lines.
Reducing that movement may limit repeated folding of the skin while the product is active.
However, facial aging also involves collagen changes, sun exposure, genetics, volume loss and other factors.
Botox and Dysport do not stop the overall aging process.
This depends on what is causing the concern.
Botox and Dysport primarily affect targeted muscle activity.
Dermal fillers add or restore volume in selected areas.
For example, expression-related frown lines may respond to a neuromodulator, while facial volume loss or contour concerns may require an entirely different approach.
Some patients may have more than one contributing factor. For a broader comparison, read our guide to Botox, dermal fillers and Sculptra.
These treatments work very differently.
Botox temporarily reduces selected muscle activity.
RF microneedling creates controlled micro-injuries while delivering radiofrequency energy to targeted tissue to encourage remodeling.
If repeated facial movement is the primary cause of a wrinkle, a neuromodulator may be more relevant.
If skin texture, acne scars or mild laxity are the main concerns, RF microneedling may be considered.
Treatment selection should be based on the underlying problem.
Before injection, the provider should evaluate your facial anatomy and observe how your face moves.
You may be asked to:
This helps identify which muscles contribute to the lines being treated.
The product is then injected into selected muscles using a small needle.
The exact injection pattern and dose depend on the product, treatment area and patient.
Injection-site redness, swelling, tenderness or bruising can occur.
Many patients can return to normal daily activities relatively quickly, but “zero downtime” should not be interpreted as a guarantee that no visible reaction will occur.
Follow the aftercare instructions provided by your treating professional.
Botulinum toxin products can cause side effects.
Possible effects can include:
Botulinum toxin products also carry important prescribing warnings.
Patients should discuss medical conditions, medications and previous reactions before treatment and review the relevant medication information.
Seek medical attention promptly for concerning symptoms after treatment.
Before treatment, tell your healthcare professional about your complete medical history and medications.
This is particularly important if you have:
Your provider can determine whether treatment is appropriate.
Some patients who previously received one botulinum toxin product may later receive another.
But switching products does not mean using the same number of units.
The products have different dosing systems.
Tell your provider which botulinum toxin product you previously received, when you received it and which areas were treated.
Instead of asking only “Which one is better?” ask:
These questions provide more useful information than comparing brands based on a single advertised difference.
Botox Cosmetic and Dysport are both botulinum toxin type A prescription products, but they are not interchangeable.
For glabellar frown lines, both have FDA-approved cosmetic indications in appropriate adults.
Botox Cosmetic also has FDA-approved cosmetic indications involving forehead lines and crow's feet.
That makes the treatment area an important part of the Botox-versus-Dysport discussion.
Ultimately, product selection should be individualized according to facial anatomy, muscle activity, treatment area, previous response and aesthetic goals.
Park Slope Laser Aesthetic Center in Brooklyn offers cosmetic injectable consultations for patients interested in reducing expression-related facial lines.
A consultation allows the provider to examine your facial movement, determine what is causing the lines that concern you, and discuss whether Botox, Dysport or another treatment approach may be appropriate.
Rather than choosing an injectable based solely on brand name, treatment should be planned around your anatomy, treatment area and desired degree of facial movement.
